{"transactions":[{"id":1840348,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":111714,"kind":"person","name":"KINGSLEY ALFRED D","position":1,"cik":"0001229339","reported_name":"KINGSLEY ALFRED D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-03T21:46:00.000Z","date":"2023-07-01","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Will vest and become exercisable on July 1, 2024, subject to the reporting person's continuous service with the issuer."}],"balance_after":50000,"derivative":{"exercise_price":1.41,"expiration_date":"2033-07-01","underlying":"Common Shares","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001493152-23-023346","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315223023346/ownership.xml","form_type":"4"}},{"id":1843372,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":111714,"kind":"person","name":"KINGSLEY ALFRED D","position":1,"cik":"0001229339","reported_name":"KINGSLEY ALFRED D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2023-06-27T21:30:12.000Z","date":"2023-06-23","kind":"grant","planned":false,"acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Options shall vest one year from the date of grant, subject to the Reporting Person's continued service as a director of the Issuer from the date of grant until the vesting date or, if earlier, until the next annual meeting of shareholders."}],"balance_after":90000,"derivative":{"exercise_price":0.2,"expiration_date":"2033-06-23","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001493152-23-022667","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1229339/000149315223022667/ownership.xml","form_type":"4"}},{"id":1843371,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":111714,"kind":"person","name":"KINGSLEY ALFRED D","position":1,"cik":"0001229339","reported_name":"KINGSLEY ALFRED D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, no par value","published_at":"2023-06-27T21:30:12.000Z","date":"2023-06-23","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Restricted Stock Units shall vest one year from the date of grant, subject to the Reporting Person's continued service as a director of the Issuer from the date of grant until the vesting date or, if earlier, until the next annual meeting of shareholders."}],"balance_after":489111,"source":{"system":"sec-edgar","filing":"0001493152-23-022667","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1229339/000149315223022667/ownership.xml","form_type":"4"}},{"id":1854089,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":111714,"kind":"person","name":"KINGSLEY ALFRED D","position":1,"cik":"0001229339","reported_name":"KINGSLEY ALFRED D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, no par value","published_at":"2023-06-15T20:13:04.000Z","date":"2023-06-14","kind":"purchase","planned":false,"acquired":true,"shares":30000,"price":0.2149,"value":6447.0,"ownership":{"direct":true},"balance_after":469111,"source":{"system":"sec-edgar","filing":"0001493152-23-021531","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1229339/000149315223021531/ownership.xml","form_type":"4"}},{"id":2017877,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":111714,"kind":"person","name":"KINGSLEY ALFRED D","position":1,"cik":"0001229339","reported_name":"KINGSLEY ALFRED D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares, no par value","published_at":"2023-02-14T21:16:07.000Z","date":"2022-12-01","kind":"gift","acquired":false,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a gift of 25,000 common shares."}],"balance_after":5430545,"source":{"system":"sec-edgar","filing":"0001493152-23-004902","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315223004902/ownership.xml","form_type":"5"}},{"id":2076022,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":111714,"kind":"person","name":"KINGSLEY ALFRED D","position":1,"cik":"0001229339","reported_name":"KINGSLEY ALFRED D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, no par value","published_at":"2022-12-27T18:47:46.000Z","date":"2022-12-22","kind":"purchase","acquired":true,"shares":25000,"price":0.285,"value":7125.0,"ownership":{"direct":true},"balance_after":439111,"source":{"system":"sec-edgar","filing":"0001493152-22-036605","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1229339/000149315222036605/ownership.xml","form_type":"4"}},{"id":2181275,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":111714,"kind":"person","name":"KINGSLEY ALFRED D","position":1,"cik":"0001229339","reported_name":"KINGSLEY ALFRED D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2022-08-17T20:20:57.000Z","date":"2022-08-15","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Options shall vest one year from the date of grant, subject to the Reporting Person's continued service as a director of the Issuer from the date of grant until the vesting date or, if earlier, until the next annual meeting of shareholders."}],"balance_after":45000,"derivative":{"exercise_price":0.97,"expiration_date":"2032-08-15","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001493152-22-023383","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1229339/000149315222023383/ownership.xml","form_type":"4"}},{"id":2181274,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":111714,"kind":"person","name":"KINGSLEY ALFRED D","position":1,"cik":"0001229339","reported_name":"KINGSLEY ALFRED D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, no par value","published_at":"2022-08-17T20:20:57.000Z","date":"2022-08-15","kind":"purchase","acquired":true,"shares":5000,"price":0.97,"value":4850.0,"ownership":{"direct":true},"balance_after":414111,"source":{"system":"sec-edgar","filing":"0001493152-22-023383","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1229339/000149315222023383/ownership.xml","form_type":"4"}},{"id":2181273,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":111714,"kind":"person","name":"KINGSLEY ALFRED D","position":1,"cik":"0001229339","reported_name":"KINGSLEY ALFRED D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, no par value","published_at":"2022-08-17T20:20:57.000Z","date":"2022-08-15","kind":"purchase","acquired":true,"shares":5000,"price":0.97,"value":4850.0,"ownership":{"direct":true},"balance_after":409111,"source":{"system":"sec-edgar","filing":"0001493152-22-023383","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1229339/000149315222023383/ownership.xml","form_type":"4"}},{"id":2181272,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":111714,"kind":"person","name":"KINGSLEY ALFRED D","position":1,"cik":"0001229339","reported_name":"KINGSLEY ALFRED D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, no par value","published_at":"2022-08-17T20:20:57.000Z","date":"2022-08-15","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Restricted Stock Units shall vest one year from the date of grant, subject to the Reporting Person's continued service as a director of the Issuer from the date of grant until the vesting date or, if earlier, until the next annual meeting of shareholders."}],"balance_after":404111,"source":{"system":"sec-edgar","filing":"0001493152-22-023383","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1229339/000149315222023383/ownership.xml","form_type":"4"}},{"id":2205190,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":111714,"kind":"person","name":"KINGSLEY ALFRED D","position":1,"cik":"0001229339","reported_name":"KINGSLEY ALFRED D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-07-19T16:05:33.000Z","date":"2022-06-24","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Restricted Stock Units vested on June 24, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Restricted Stock Units vested on June 24, 2022."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001493152-22-019820","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1229339/000149315222019820/ownership.xml","form_type":"4"}},{"id":2205189,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":111714,"kind":"person","name":"KINGSLEY ALFRED D","position":1,"cik":"0001229339","reported_name":"KINGSLEY ALFRED D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, no par value","published_at":"2022-07-19T16:05:33.000Z","date":"2022-06-24","kind":"exercise","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":394111,"source":{"system":"sec-edgar","filing":"0001493152-22-019820","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1229339/000149315222019820/ownership.xml","form_type":"4"}},{"id":2213192,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":111714,"kind":"person","name":"KINGSLEY ALFRED D","position":1,"cik":"0001229339","reported_name":"KINGSLEY ALFRED D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-07-06T20:15:46.000Z","date":"2022-07-01","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Will vest and become exercisable on July 1, 2023, subject to the reporting person's continuous service with the issuer."}],"balance_after":50000,"derivative":{"exercise_price":1.57,"expiration_date":"2032-07-01","underlying":"Common Shares","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001493152-22-018681","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315222018681/ownership.xml","form_type":"4"}},{"id":2402769,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":111714,"kind":"person","name":"KINGSLEY ALFRED D","position":1,"cik":"0001229339","reported_name":"KINGSLEY ALFRED D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares, no par value","published_at":"2022-02-11T21:15:32.000Z","date":"2021-12-01","kind":"gift","acquired":false,"shares":14700,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"During December 2021, Mr. Kingsley gifted a total of 14,700 common shares."}],"balance_after":5455545,"source":{"system":"sec-edgar","filing":"0001493152-22-004013","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315222004013/ownership.xml","form_type":"5"}},{"id":2648698,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":111714,"kind":"person","name":"KINGSLEY ALFRED D","position":1,"cik":"0001229339","reported_name":"KINGSLEY ALFRED D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-07-01T22:21:59.000Z","date":"2021-07-01","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Will vest and become exercisable on July 1, 2022, subject to the reporting person's continuous service with the issuer."}],"balance_after":80000,"derivative":{"exercise_price":2.86,"expiration_date":"2031-07-01","underlying":"Common Shares","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001493152-21-015884","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315221015884/ownership.xml","form_type":"4"}},{"id":2653210,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":111714,"kind":"person","name":"KINGSLEY ALFRED D","position":1,"cik":"0001229339","reported_name":"KINGSLEY ALFRED D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-06-28T20:32:33.000Z","date":"2021-06-24","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Restricted Stock Units shall vest one year from the date of grant, subject to the director's continued service as a director of the Company from the date of grant until the vesting date or, if earlier, until the next annual meeting of shareholders."}],"balance_after":10000,"derivative":{"exercise_price":0,"exercise_date":"2022-06-24","expiration_date":"2022-06-24","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001493152-21-015448","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1229339/000149315221015448/ownership.xml","form_type":"4"}},{"id":2653209,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":111714,"kind":"person","name":"KINGSLEY ALFRED D","position":1,"cik":"0001229339","reported_name":"KINGSLEY ALFRED D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2021-06-28T20:32:33.000Z","date":"2021-06-24","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options shall vest one year from the date of grant, subject to the director's continued service as a director of the Company from the date of grant until the vesting date or,if earlier, until the next annual meeting of shareholders."}],"balance_after":45000,"derivative":{"exercise_price":5.46,"expiration_date":"2031-06-23","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001493152-21-015448","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1229339/000149315221015448/ownership.xml","form_type":"4"}},{"id":2657853,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":111714,"kind":"person","name":"KINGSLEY ALFRED D","position":1,"cik":"0001229339","reported_name":"KINGSLEY ALFRED D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-23T17:15:19.000Z","date":"2021-06-22","kind":"exercise","acquired":false,"shares":61800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option became exercisable in four equal quarterly installments after the date of grant on July 1, 2016."}],"balance_after":0,"derivative":{"exercise_price":2.2,"expiration_date":"2021-06-30","underlying":"Common Shares","underlying_shares":61800},"source":{"system":"sec-edgar","filing":"0001493152-21-015072","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315221015072/ownership.xml","form_type":"4"}},{"id":2657852,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":111714,"kind":"person","name":"KINGSLEY ALFRED D","position":1,"cik":"0001229339","reported_name":"KINGSLEY ALFRED D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares, no par value","published_at":"2021-06-23T17:15:19.000Z","date":"2021-06-22","kind":"exercise","acquired":true,"shares":61800,"price":2.2,"value":135960.0,"ownership":{"direct":true},"balance_after":5470245,"source":{"system":"sec-edgar","filing":"0001493152-21-015072","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315221015072/ownership.xml","form_type":"4"}},{"id":2864593,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":111714,"kind":"person","name":"KINGSLEY ALFRED D","position":1,"cik":"0001229339","reported_name":"KINGSLEY ALFRED D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares, no par value","published_at":"2021-02-12T22:00:28.000Z","date":"2020-12-01","kind":"gift","acquired":false,"shares":17500,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"During December 2020, Mr. Kingsley gifted a total of 17,500 common shares."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"During December 2020, Mr. Kingsley gifted a total of 17,500 common shares."}],"balance_after":5408445,"source":{"system":"sec-edgar","filing":"0001493152-21-003685","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315221003685/ownership.xml","form_type":"5"}},{"id":2931089,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":111714,"kind":"person","name":"KINGSLEY ALFRED D","position":1,"cik":"0001229339","reported_name":"KINGSLEY ALFRED D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2020-12-28T21:46:58.000Z","date":"2020-12-28","kind":"exercise","acquired":true,"shares":65271,"price":1.34,"value":87463.14,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options vested and became exercisable in equal quarterly installments on the last day of each calendar quarter over a four-year period from the date of grant on December 29, 2010."}],"balance_after":0,"derivative":{"exercise_price":1.34,"expiration_date":"2020-12-28","underlying":"Common Stock","underlying_shares":65271},"source":{"system":"sec-edgar","filing":"0001493152-20-024410","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1229339/000149315220024410/ownership.xml","form_type":"4"}},{"id":2931088,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":111714,"kind":"person","name":"KINGSLEY ALFRED D","position":1,"cik":"0001229339","reported_name":"KINGSLEY ALFRED D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2020-12-28T21:46:58.000Z","date":"2020-12-23","kind":"exercise","acquired":true,"shares":1237,"price":1.34,"value":1657.58,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options vested and became exercisable in equal quarterly installments on the last day of each calendar quarter over a four-year period from the date of grant on December 29, 2010."}],"balance_after":65271,"derivative":{"exercise_price":1.34,"expiration_date":"2020-12-28","underlying":"Common Stock","underlying_shares":1237},"source":{"system":"sec-edgar","filing":"0001493152-20-024410","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1229339/000149315220024410/ownership.xml","form_type":"4"}},{"id":2931087,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":111714,"kind":"person","name":"KINGSLEY ALFRED D","position":1,"cik":"0001229339","reported_name":"KINGSLEY ALFRED D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, no par value","published_at":"2020-12-28T21:46:58.000Z","date":"2020-12-28","kind":"exercise","acquired":true,"shares":65271,"price":1.34,"value":87463.14,"ownership":{"direct":true},"balance_after":384111,"source":{"system":"sec-edgar","filing":"0001493152-20-024410","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1229339/000149315220024410/ownership.xml","form_type":"4"}},{"id":2931086,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":111714,"kind":"person","name":"KINGSLEY ALFRED D","position":1,"cik":"0001229339","reported_name":"KINGSLEY ALFRED D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, no par value","published_at":"2020-12-28T21:46:58.000Z","date":"2020-12-23","kind":"sale","acquired":false,"shares":900,"price":2.55,"value":2295.0,"ownership":{"direct":true},"balance_after":318840,"source":{"system":"sec-edgar","filing":"0001493152-20-024410","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1229339/000149315220024410/ownership.xml","form_type":"4"}},{"id":2931085,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":111714,"kind":"person","name":"KINGSLEY ALFRED D","position":1,"cik":"0001229339","reported_name":"KINGSLEY ALFRED D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, no par value","published_at":"2020-12-28T21:46:58.000Z","date":"2020-12-23","kind":"exercise","acquired":true,"shares":1237,"price":1.34,"value":1657.58,"ownership":{"direct":true},"balance_after":319740,"source":{"system":"sec-edgar","filing":"0001493152-20-024410","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1229339/000149315220024410/ownership.xml","form_type":"4"}},{"id":2932660,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":111714,"kind":"person","name":"KINGSLEY ALFRED D","position":1,"cik":"0001229339","reported_name":"KINGSLEY ALFRED D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2020-12-23T21:12:13.000Z","date":"2020-12-22","kind":"exercise","acquired":true,"shares":10516,"price":1.34,"value":14091.44,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The options vested and became exercisable in equal quarterly installments on the last day of each calendar quarter over a four-year period from the date of grant on December 29, 2010."}],"balance_after":66508,"derivative":{"exercise_price":1.34,"expiration_date":"2020-12-28","underlying":"Common Stock","underlying_shares":10516},"source":{"system":"sec-edgar","filing":"0001493152-20-024283","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1229339/000149315220024283/ownership.xml","form_type":"4"}},{"id":2932659,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":111714,"kind":"person","name":"KINGSLEY ALFRED D","position":1,"cik":"0001229339","reported_name":"KINGSLEY ALFRED D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2020-12-23T21:12:13.000Z","date":"2020-12-21","kind":"exercise","acquired":true,"shares":47976,"price":1.34,"value":64287.84,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The options vested and became exercisable in equal quarterly installments on the last day of each calendar quarter over a four-year period from the date of grant on December 29, 2010."}],"balance_after":77024,"derivative":{"exercise_price":1.34,"expiration_date":"2020-12-28","underlying":"Common Stock","underlying_shares":47976},"source":{"system":"sec-edgar","filing":"0001493152-20-024283","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1229339/000149315220024283/ownership.xml","form_type":"4"}},{"id":2932658,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":111714,"kind":"person","name":"KINGSLEY ALFRED D","position":1,"cik":"0001229339","reported_name":"KINGSLEY ALFRED D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, no par value","published_at":"2020-12-23T21:12:13.000Z","date":"2020-12-22","kind":"sale","acquired":false,"shares":7652,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Shares sold at price ranging from $2.54 - $2.55."}],"balance_after":318503,"source":{"system":"sec-edgar","filing":"0001493152-20-024283","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1229339/000149315220024283/ownership.xml","form_type":"4"}},{"id":2932657,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":111714,"kind":"person","name":"KINGSLEY ALFRED D","position":1,"cik":"0001229339","reported_name":"KINGSLEY ALFRED D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, no par value","published_at":"2020-12-23T21:12:13.000Z","date":"2020-12-22","kind":"exercise","acquired":true,"shares":10516,"price":1.34,"value":14091.44,"ownership":{"direct":true},"balance_after":326155,"source":{"system":"sec-edgar","filing":"0001493152-20-024283","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1229339/000149315220024283/ownership.xml","form_type":"4"}},{"id":2932656,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":111714,"kind":"person","name":"KINGSLEY ALFRED D","position":1,"cik":"0001229339","reported_name":"KINGSLEY ALFRED D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, no par value","published_at":"2020-12-23T21:12:13.000Z","date":"2020-12-21","kind":"sale","acquired":false,"shares":5148,"price":2.54,"value":13075.92,"ownership":{"direct":true},"balance_after":315639,"source":{"system":"sec-edgar","filing":"0001493152-20-024283","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1229339/000149315220024283/ownership.xml","form_type":"4"}},{"id":2932655,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":111714,"kind":"person","name":"KINGSLEY ALFRED D","position":1,"cik":"0001229339","reported_name":"KINGSLEY ALFRED D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, no par value","published_at":"2020-12-23T21:12:13.000Z","date":"2020-12-21","kind":"sale","acquired":false,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares sold at price ranging from $2.50 - $2.54."}],"balance_after":320787,"source":{"system":"sec-edgar","filing":"0001493152-20-024283","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1229339/000149315220024283/ownership.xml","form_type":"4"}},{"id":2932654,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":111714,"kind":"person","name":"KINGSLEY ALFRED D","position":1,"cik":"0001229339","reported_name":"KINGSLEY ALFRED D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, no par value","published_at":"2020-12-23T21:12:13.000Z","date":"2020-12-21","kind":"exercise","acquired":true,"shares":47976,"price":1.34,"value":64287.84,"ownership":{"direct":true},"balance_after":350787,"source":{"system":"sec-edgar","filing":"0001493152-20-024283","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1229339/000149315220024283/ownership.xml","form_type":"4"}},{"id":2944182,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":111714,"kind":"person","name":"KINGSLEY ALFRED D","position":1,"cik":"0001229339","reported_name":"KINGSLEY ALFRED D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-15T06:15:35.000Z","date":"2020-12-11","kind":"grant","acquired":true,"shares":5909,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of the Issuer's common stock were issued to the Reporting Person for the repayment of deferred compensation in lieu of cash at a price of $2.07 per share."}],"balance_after":302811,"source":{"system":"sec-edgar","filing":"0001493152-20-023586","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1229339/000149315220023586/ownership.xml","form_type":"4"}},{"id":3093734,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":111714,"kind":"person","name":"KINGSLEY ALFRED D","position":1,"cik":"0001229339","reported_name":"KINGSLEY ALFRED D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-02T21:00:55.000Z","date":"2020-07-01","kind":"grant","acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Will become exercisable on July 1, 2021, based upon continued service on the board of directors."}],"balance_after":70000,"derivative":{"exercise_price":0.8263,"expiration_date":"2030-07-01","underlying":"Common Shares","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001493152-20-012529","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315220012529/ownership.xml","form_type":"4"}},{"id":3104124,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":111714,"kind":"person","name":"KINGSLEY ALFRED D","position":1,"cik":"0001229339","reported_name":"KINGSLEY ALFRED D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2020-06-19T17:34:07.000Z","date":"2020-06-17","kind":"grant","acquired":true,"shares":57000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options shall vest one year from the date of grant, subject to the director's continued service as a director of the Company or a subsidiary from the date of grant until the vesting date or, if earlier, until the next annual meeting of shareholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Options shall vest one year from the date of grant, subject to the director's continued service as a director of the Company or a subsidiary from the date of grant until the vesting date or, if earlier, until the next annual meeting of shareholders."}],"balance_after":57000,"derivative":{"exercise_price":2.38,"underlying":"Common Stock","underlying_shares":57000},"source":{"system":"sec-edgar","filing":"0001493152-20-011541","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1229339/000149315220011541/ownership.xml","form_type":"4"}},{"id":3272069,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":111714,"kind":"person","name":"KINGSLEY ALFRED D","position":1,"cik":"0001229339","reported_name":"KINGSLEY ALFRED D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares, no par value","published_at":"2020-02-14T21:45:23.000Z","date":"2019-09-01","kind":"gift","acquired":false,"shares":32000,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"During September 2019, Mr. Kingsley gifted a total of 32,000 common shares."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"During September 2019, Mr. Kingsley gifted a total of 32,000 common shares."}],"balance_after":5425945,"source":{"system":"sec-edgar","filing":"0001493152-20-002547","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315220002547/ownership.xml","form_type":"5"}},{"id":3458451,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":111714,"kind":"person","name":"KINGSLEY ALFRED D","position":1,"cik":"0001229339","reported_name":"KINGSLEY ALFRED D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2019-07-19T20:23:42.000Z","date":"2019-07-17","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options shall vest one year from the date of grant, subject to the director's continued service as a director of the Company or a subsidiary from the date of grant until the vesting date or, if earlier, until the next annual meeting of shareholders."}],"balance_after":45000,"derivative":{"exercise_price":2.12,"expiration_date":"2029-07-16","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001209191-19-042845","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1229339/000120919119042845/doc4.xml","form_type":"4"}},{"id":3469524,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":111714,"kind":"person","name":"KINGSLEY ALFRED D","position":1,"cik":"0001229339","reported_name":"KINGSLEY ALFRED D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-07-04T01:15:52.000Z","date":"2019-07-01","kind":"grant","acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Will become exercisable on June 30, 2020, based upon continued service on the board of directors."}],"balance_after":70000,"derivative":{"exercise_price":1.03,"expiration_date":"2029-06-30","underlying":"Common Shares","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001209191-19-041308","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000120919119041308/doc4.xml","form_type":"4"}},{"id":3562132,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":111714,"kind":"person","name":"KINGSLEY ALFRED D","position":1,"cik":"0001229339","reported_name":"KINGSLEY ALFRED D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares, no par value","published_at":"2019-04-05T23:10:00.000Z","date":"2019-03-08","kind":"grant","acquired":true,"shares":6390,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Acquired pursuant to that certain Agreement and Plan of Merger, dated November 7, 2018 (the \"Merger Agreement\"), by and between the Issuer, Patrick Merger Sub, Inc., a Delaware corporation and wholly-owned subsidiary of the Issuer, and Asterias Biotherapeutics, Inc., a Delaware corporation (\"Asterias\").  Pursuant to the Merger Agreement, each share of Series A common stock of Asterias was converted into the right to receive 0.71 common shares of the Issuer."},{"field":"shares","element":"transactionShares","label":"F1","text":"Acquired pursuant to that certain Agreement and Plan of Merger, dated November 7, 2018 (the \"Merger Agreement\"), by and between the Issuer, Patrick Merger Sub, Inc., a Delaware corporation and wholly-owned subsidiary of the Issuer, and Asterias Biotherapeutics, Inc., a Delaware corporation (\"Asterias\").  Pursuant to the Merger Agreement, each share of Series A common stock of Asterias was converted into the right to receive 0.71 common shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Acquired pursuant to that certain Agreement and Plan of Merger, dated November 7, 2018 (the \"Merger Agreement\"), by and between the Issuer, Patrick Merger Sub, Inc., a Delaware corporation and wholly-owned subsidiary of the Issuer, and Asterias Biotherapeutics, Inc., a Delaware corporation (\"Asterias\").  Pursuant to the Merger Agreement, each share of Series A common stock of Asterias was converted into the right to receive 0.71 common shares of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Does not include shares that Mr. Kingsley may acquire through the exercise of certain options."}],"balance_after":5457945,"source":{"system":"sec-edgar","filing":"0001209191-19-023894","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000120919119023894/doc4.xml","form_type":"4"}},{"id":3658314,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":111714,"kind":"person","name":"KINGSLEY ALFRED D","position":1,"cik":"0001229339","reported_name":"KINGSLEY ALFRED D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares, no par value","published_at":"2019-02-15T01:47:43.000Z","date":"2018-11-01","kind":"gift","acquired":false,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"During November 2018, Mr. Kingsley gifted a total of 20,000 common shares."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"During November 2018, Mr. Kingsley gifted a total of 20,000 common shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Does not include shares that Mr. Kingsley may acquire through the exercise of certain options."}],"balance_after":5451555,"source":{"system":"sec-edgar","filing":"0001209191-19-010466","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000120919119010466/doc5.xml","form_type":"5"}},{"id":3827119,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":111714,"kind":"person","name":"KINGSLEY ALFRED D","position":1,"cik":"0001229339","reported_name":"KINGSLEY ALFRED D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2018-09-04T21:51:33.000Z","date":"2018-08-30","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options shall vest one year from the date of grant, subject to the director's continued service as a director of the Company or a subsidiary from the date of grant until the vesting date or, if earlier, until the next annual meeting of shareholders."}],"balance_after":45000,"derivative":{"exercise_price":2.4,"expiration_date":"2028-08-29","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001209191-18-049416","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1229339/000120919118049416/doc4.xml","form_type":"4"}},{"id":3877049,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":111714,"kind":"person","name":"KINGSLEY ALFRED D","position":1,"cik":"0001229339","reported_name":"KINGSLEY ALFRED D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Option to Purchase Common Shares","published_at":"2018-07-03T22:47:36.000Z","date":"2018-07-01","kind":"grant","acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Will become exercisable on June 30, 2019, based upon continued service on the board of directors."}],"balance_after":70000,"derivative":{"exercise_price":2.06,"expiration_date":"2023-06-30","underlying":"Common Shares","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001209191-18-041312","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/876343/000120919118041312/doc4.xml","form_type":"4"}},{"id":4060730,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":111714,"kind":"person","name":"KINGSLEY ALFRED D","position":1,"cik":"0001229339","reported_name":"KINGSLEY ALFRED D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Shares, no par value","published_at":"2018-02-15T02:48:46.000Z","date":"2017-12-01","kind":"gift","acquired":false,"shares":100000,"ownership":{"direct":false,"nature":"By Greenbelt Corp."},"footnotes":[{"field":"date","element":"transactionDate","label":"F3","text":"During December 2017, Greenbelt Corp. gifted a total of 100,000 common shares to certain charitable organizations."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"During December 2017, Greenbelt Corp. gifted a total of 100,000 common shares to certain charitable organizations."}],"balance_after":1043346,"source":{"system":"sec-edgar","filing":"0001209191-18-010227","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/876343/000120919118010227/doc5.xml","form_type":"5"}},{"id":4060729,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":111714,"kind":"person","name":"KINGSLEY ALFRED D","position":1,"cik":"0001229339","reported_name":"KINGSLEY ALFRED D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Shares, no par value","published_at":"2018-02-15T02:48:46.000Z","date":"2017-10-01","kind":"gift","acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"During October 2017, Mr. Kingsley gifted a total of 10,000 common shares."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"During October 2017, Mr. Kingsley gifted a total of 10,000 common shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Does not include shares that Mr. Kingsley may acquire through the exercise of certain options."}],"balance_after":5471555,"source":{"system":"sec-edgar","filing":"0001209191-18-010227","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000120919118010227/doc5.xml","form_type":"5"}},{"id":4228912,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":111714,"kind":"person","name":"KINGSLEY ALFRED D","position":1,"cik":"0001229339","reported_name":"KINGSLEY ALFRED D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Shares, no par value","published_at":"2017-08-22T01:21:16.000Z","date":"2017-08-17","kind":"disposition_to_issuer","acquired":false,"shares":300000,"price":2.81,"value":843000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On August 17, 2017, Mr. Kingsley exchanged 300,000 BioTime common shares for 421,500 common shares of AgeX Therapeutics, Inc., a subsidiary of BioTime."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Does not include shares that Mr. Kingsley may acquire through the exercise of certain options."}],"balance_after":5481555,"source":{"system":"sec-edgar","filing":"0001209191-17-049764","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000120919117049764/doc4.xml","form_type":"4"}},{"id":4246384,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":111714,"kind":"person","name":"KINGSLEY ALFRED D","position":1,"cik":"0001229339","reported_name":"KINGSLEY ALFRED D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Shares, no par value","published_at":"2017-08-02T22:27:35.000Z","date":"2017-07-31","kind":"sale","acquired":false,"shares":150000,"price":2.8,"value":420000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The securities were sold in a private transaction. Substantially all of the sale proceeds were invested in AgeX Therapeutics, Inc., a new subsidiary of BioTime."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Does not include shares that Mr. Kingsley may acquire through the exercise of certain options."}],"balance_after":5781555,"source":{"system":"sec-edgar","filing":"0001209191-17-047197","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000120919117047197/doc4.xml","form_type":"4"}},{"id":4266119,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":111714,"kind":"person","name":"KINGSLEY ALFRED D","position":1,"cik":"0001229339","reported_name":"KINGSLEY ALFRED D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Option to Purchase Common Shares","published_at":"2017-07-06T00:34:46.000Z","date":"2017-07-01","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Will become exercisable in four equal quarterly installments after the date of grant on July 1, 2017 based upon continued service on the board of directors."}],"balance_after":50000,"derivative":{"exercise_price":3.15,"expiration_date":"2022-06-30","underlying":"Common Shares","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-17-043821","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/876343/000120919117043821/doc4.xml","form_type":"4"}},{"id":4277235,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":111714,"kind":"person","name":"KINGSLEY ALFRED D","position":1,"cik":"0001229339","reported_name":"KINGSLEY ALFRED D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2017-06-19T21:23:03.000Z","date":"2017-06-15","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Will become exercisable in four equal installments on September 30, 2017, December 31, 2017, March 31, 2018, and one day before the Company's next annual meeting of shareholders, based upon continued service on the board of directors from the date of grant on June 15, 2017."}],"balance_after":50000,"derivative":{"exercise_price":5.1,"expiration_date":"2027-06-14","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-17-040980","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1229339/000120919117040980/doc4.xml","form_type":"4"}},{"id":4277234,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":111714,"kind":"person","name":"KINGSLEY ALFRED D","position":1,"cik":"0001229339","reported_name":"KINGSLEY ALFRED D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2017-06-19T21:23:03.000Z","date":"2017-06-15","kind":"grant","acquired":true,"shares":16300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Options are granted to directors annually. These options are a \"transitional grant\" reflecting the change in the date of the annual grant from February to the date of the annual meeting of shareholders. The options are 32.60% of the annual grant for the 119-day gap between February 16, 2017, one year from the last annual grant, and June 15, 2017, date of the full annual grant for 2017-2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Will become exercisable in four equal installments on September 30, 2017, December 31, 2017, March 31, 2018, and one day before the Company's next annual meeting of shareholders, based upon continued service on the board of directors from the date of grant on June 15, 2017."}],"balance_after":16300,"derivative":{"exercise_price":5.1,"expiration_date":"2027-06-14","underlying":"Common Stock","underlying_shares":16300},"source":{"system":"sec-edgar","filing":"0001209191-17-040980","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1229339/000120919117040980/doc4.xml","form_type":"4"}},{"id":4496979,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":111714,"kind":"person","name":"KINGSLEY ALFRED D","position":1,"cik":"0001229339","reported_name":"KINGSLEY ALFRED D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Shares, no par value","published_at":"2017-01-07T02:56:55.000Z","date":"2017-01-03","kind":"other","acquired":false,"shares":238469,"ownership":{"direct":false,"nature":"By Greenbelt Corp."},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Distribution to a shareholder in partial redemption of their shares of Greenbelt Corp. None of Mr. Kingsley's shares in Greenbelt Corp. have been redeemed."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Distribution to a shareholder in partial redemption of their shares of Greenbelt Corp. None of Mr. Kingsley's shares in Greenbelt Corp. have been redeemed."}],"balance_after":1143346,"source":{"system":"sec-edgar","filing":"0001209191-17-002818","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000120919117002818/doc4.xml","form_type":"4"}},{"id":4496975,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":111714,"kind":"person","name":"KINGSLEY ALFRED D","position":1,"cik":"0001229339","reported_name":"KINGSLEY ALFRED D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Shares, no par value","published_at":"2017-01-07T02:47:37.000Z","date":"2016-12-01","kind":"gift","acquired":false,"shares":69300,"ownership":{"direct":false,"nature":"By Greenbelt Corp."},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"During December 2016, Greenbelt Corp. gifted a total of 69,300 common shares to certain charitable organizations."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"During December 2016, Greenbelt Corp. gifted a total of 69,300 common shares to certain charitable organizations."}],"balance_after":1381805,"source":{"system":"sec-edgar","filing":"0001209191-17-002813","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/876343/000120919117002813/doc5.xml","form_type":"5"}}]}